Generics 194

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Tobramycin manufacturers

194 products found

Filters

194 products found

tobramycin

Ampoules, injection 300 mg/5 ml - 5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
France , Germany , Italy , Portugal , United Kingdom , Vietnam
Registered in
France , Germany , Italy , Portugal , United Kingdom
Comments
Cold chain product (2-8ªC). No stability zone 4 data required.
Manufacturer #15084

Manufacturer usually replies in 18 days

tobramycin

Nebuliser solution 300 mg/5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Italy
Registered in
Poland , Hungary , Romania , Bulgaria , Lithuania , Latvia , Estonia
Available for
Licensing with supply, Distribution only
MAs for sale
Hungary , Romania
Manufacturer #21025

Manufacturer usually replies in 1 days

tobramycin

Eye drops 3 mg/ml - 5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Vietnam
Manufacturer #12923
It is the successor of one of the largest pharmaceutical manufacturers in southeast Europe. To date, it has been present over 60 years of experience in the development, production, and sale of generic drugs for human and veterinary use. It has a pharmaceutical plant with facilities for the production of the following dosage forms: capsules and tablets, liquid sterile and dry injection forms, semi-solid forms, creams, and ointments for skin and eye use. The plant has the necessary production licenses and certificates of GMP for all productions.

Manufacturer usually replies in 9 days

tobramycin + dexamethasone

Eye ointment 3 mg/g + 1 mg/g - 5 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Lebanon , Vietnam
Manufacturer #12923
It is the successor of one of the largest pharmaceutical manufacturers in southeast Europe. To date, it has been present over 60 years of experience in the development, production, and sale of generic drugs for human and veterinary use. It has a pharmaceutical plant with facilities for the production of the following dosage forms: capsules and tablets, liquid sterile and dry injection forms, semi-solid forms, creams, and ointments for skin and eye use. The plant has the necessary production licenses and certificates of GMP for all productions.

Manufacturer usually replies in 9 days

tobramycin

Eye ointment 3 mg/g - 5 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Lebanon , Vietnam
Comments
Our dossier does not contain in vitro test
Manufacturer #12923
It is the successor of one of the largest pharmaceutical manufacturers in southeast Europe. To date, it has been present over 60 years of experience in the development, production, and sale of generic drugs for human and veterinary use. It has a pharmaceutical plant with facilities for the production of the following dosage forms: capsules and tablets, liquid sterile and dry injection forms, semi-solid forms, creams, and ointments for skin and eye use. The plant has the necessary production licenses and certificates of GMP for all productions.

Manufacturer usually replies in 9 days

tobramycin

Solution for injection 100 mg - 2 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq
Manufacturer #17659
It was established in the 1970s as the result of an industrial initiative targeted at the production of injectable pharmaceuticals in the form of solutions, suspensions, and powders. It works with several Italian and international universities to research and develop novel manufacturing methods for the generic medication market. The company has advanced laboratories for chemical, physical, and microbiological controls to assist production.

Manufacturer usually replies in 8 days

tobramycin

Nebuliser solution 170 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17277
It is a European giant with a global distribution network and overseas branch offices are also available. The company's approximately 500 employees and stable management team can look back on a more than 100-year history. PARI has been a trusted name for doctors, pharmacists, and patients for decades as a maker of medical devices with a concentration on inhalation devices.

Manufacturer usually replies in 6 days

tobramycin

Eye drops 0.3 % - 5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Albania , Austria , Belgium , Bosnia And Herzegovina , Bulgaria , Croatia , Cyprus , Czech Republic , Denmark , Estonia , Finland , France , Germany , Hungary , Ireland , Italy , Latvia , North Macedonia , Moldova , Netherlands , Norway , Poland , Portugal , Serbia , Spain , Sweden , Switzerland , United Kingdom , Iraq , United Arab Emirates
Available for
Licensing with supply
Manufacturer #9267

A highly trusted and reliable name for WHO-approved pharmaceutical products that deals in exports as well. With modern facilities and excellent product conditions, they are known to provide superlative services aimed at keeping the community disease-free and healthy at the same time.

Manufacturer usually replies in 8 days

tobramycin + dexamethasone

Eye drops (3mg+1mg)/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #376
A pharmaceutical manufacturer based in the EU that has been active in EU, CIS, Middle East, North America, and Africa selling its products for 40+ years. Key production lines are Rx and OTC. Main therapeutic areas include cardiology, urology, respiratory system, and oncology. The company's production lines are GMP-compliant. Main dosage forms include solids, semi-solid, liquid, and sterile products.

Manufacturer usually replies in 6 days

tobramycin

Eye drops 0,3%

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
Manufacturer #554

Manufacturer usually replies in 3 days

tobramycin + dexamethasone

Eye drops 0,3%+0,1%

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
Manufacturer #554

Manufacturer usually replies in 3 days

tobramycin

Eye drops 0,3%

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
Manufacturer #457

Manufacturer usually replies in 2 days

tobramycin

Nebuliser solution 300 mg/5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Tobi®Novartis
Manufacturer #8822
A pharmaceutical manufacturer based in Europe that has been active in 60+ countries selling its products in Europe, North America, LATAM, MENA, and Asia for 50+ years. The main therapeutic areas include CNS, ophthalmology, and dermatology. Main dosage forms include sterile and solid oral dosage forms. The company's production lines are cGMP-compliant. The company possesses branches in Europe, North America, and Asia.

Manufacturer usually replies in 5 days

tobramycin

Eye drops 3 mg/ml - 0.25 ml, 5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Manufacturer #6580
A pharmaceutical manufacturer based in the EU that has been active in 20+ countries selling its products in Europe, MENA, LATAM, Asia, and NA for 20+ years. Key production lines are Rx and medical devices. Main therapeutic areas include oncology and respiratory. The company's production lines are GMP-compliant.

Manufacturer usually replies in 11 days

tobramycin

Vials, injection 3 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #447
A pharmaceutical manufacturer based in the EU that is active in 20+ countries selling its products in Europe, Africa, Middle East, North America, LATAM, and Asia for 60+ years. The company owns manufactories in Europe and NA that are GMP-compliant. Main therapeutic areas include gastroenterology, ophthalmology, and otolaryngology. The company has branches in Europe, North America, LATAM, and Africa.

Manufacturer usually replies in 25 days

tobramycin

Vials, injection 0.3% - 5 ml

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #18871

Manufacturer usually replies in 4 days

tobramycin

Solution for injection 500 mg in 5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Australia
GMP approvals
TGA
Manufacturer #13731
It is a European-owned company dedicated to providing training and job opportunities in the domains of research and development as well as commercial product production for both domestic and international markets. Over 65 drugs in essential therapeutic areas are supplied by them. It also sells and licenses items all over the world, including the Pacific, Asia, Europe, Canada, the Americas, and the Middle East

Manufacturer usually replies in 9 days

tobramycin + dexamethasone

Eye ointment 0.3 %, 0.1 %

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Unavailable markets
United States
Manufacturer #28190

Manufacturer usually replies in 8 days

tobramycin + dexamethasone

Eye drops 0.3%+0.1%

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
EU GMP
Manufacturer #11554
It is the leading pharmaceutical company specializing in ophthalmic products. The company has acquired EU GMP certification and has been under preparation for CGMP approval for both manufacturing sites of multi-dose and single-dose products.

Manufacturer usually replies in 6 days

tobramycin

Eye drops 0.3%

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
EU GMP
Manufacturer #11554
It is the leading pharmaceutical company specializing in ophthalmic products. The company has acquired EU GMP certification and has been under preparation for CGMP approval for both manufacturing sites of multi-dose and single-dose products.

Manufacturer usually replies in 6 days

Want to view all 194 products? Create your free account today!

Tobramycin Manufactureres

This medication is used to treat eye infections. Tobramycin is an aminoglycoside antibiotic, which implies it belongs to a class of antibiotics called aminoglycosides. It acts by blocking the growth of germs. Tobramycin is only used to treat bacterial eye infections. This treatment will not work for other types of eye infections. If antibiotics are used excessively or unnecessarily, their efficacy may be lost. Bethkis, Kitabis, Tobi, Tobradex, Tobrex, Zylet, Tobi Podhaler Weekly Kit and other brands are available. How to use tobramycin - Before using eye drops, make sure your hands are clean. Do not touch the dropper tip or allow it to come into contact with your eye or any other surface to avoid contamination. Wearing contact lenses while taking this medication is not recommended. Before using contact lenses, sterilise them according to the manufacturer's instructions and consult your doctor. How Tobramycin works - Tobramycin is an aminoglycoside antibiotic having a 4,6-disubstituted 2-deoxystreptamine (DOS) ring that is active against Gram-negative and Gram-positive bacteria. 13,14,15 Tobramycin's mechanism of action isn't completely understood, and some theories rely on findings with related aminoglycosides. Dosage - 6 to 7.5 mg/kg/day IV or IM, divided into 3 to 4 doses (2 to 2.5 mg/kg every 8 hours or 1.5 to 1.89 mg/kg/dose IV or IM every 6 hours), is the FDA-approved dose. Four to seven days of treatment is suggested.

Price of Tobramycin

Depending on the drugstore you visit, tobramycin ophthalmic ophthalmic solution 0.3 percent costs roughly $14 for a supply of 5 millilitres. Prices are only valid for cash paying consumers and do not apply to insurance programmes. tobramycin is most commonly found in the pharmaceutical industry. In reality, the price varies depending on the country from whence the order was placed.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Tobramycin offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for Tobramycin manufacturers and Tobramycin suppliers that you are looking for. These also enable you to check the dossier status of Tobramycin and the GMP approvals of the different variants of Tobramycin. Also, each manufacturer or supplier product description contains essential information about Hyaluronic Acid Including clinical data, stability zones, countries whereTobramycin is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over Tobramycin offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that Tobramycin manufacturers list has, we qualify their companies before they are on boarded on the platform. This allows us to screen Tobramycin manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.